Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
WDFY4 deficiency in NOD mice ameliorates autoimmune diabetes and insulitis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 20, 2023
IL-6 selectively suppresses cDC1 specification via C/EBPβ.
Journal: The Journal of experimental medicine
Published: October 14, 2022
Enhanced in vitro type 1 conventional dendritic cell generation via the recruitment of hematopoietic stem cells and early progenitors by Kit ligand.
Journal: European journal of immunology
Published: October 06, 2022
DCs at the center of help: Origins and evolution of the three-cell-type hypothesis.
Journal: The Journal of experimental medicine
Published: February 10, 2022
Mechanisms of CD40-dependent cDC1 licensing beyond costimulation.
Journal: Nature immunology
Published: December 21, 2021
cDC1 Vaccines Drive Tumor Rejection by Direct Presentation Independently of Host cDC1.
Journal: Cancer immunology research
Published: October 11, 2021
Ablation of cDC2 development by triple mutations within the Zeb2 enhancer.
Journal: Nature
Published: April 25, 2021
cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity.
Journal: Nature
Published: December 03, 2019
Bcl6-Independent In Vivo Development of Functional Type 1 Classical Dendritic Cells Supporting Tumor Rejection.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 23, 2019
Long-Term Culture Captures Injury-Repair Cycles of Colonic Stem Cells.
Journal: Cell
Published: February 26, 2019
Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.
Journal: Nature immunology
Published: November 20, 2018
Last Updated: 09/26/2026